Canada markets close in 29 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1000+0.0150 (+17.65%)
As of 02:02PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
2,358
1,608
1,342
1,694
506.273
Cost of Revenue
1,216
1,039
814.715
1,084
390.802
Gross Profit
1,142
568.441
526.859
609.912
115.471
Operating Expenses
Research Development
1,617
1,377
1,326
1,541
922.526
Selling General and Administrative
4,377
4,075
3,425
2,659
2,372
Total Operating Expenses
5,993
5,452
4,751
4,200
3,294
Operating Income or Loss
-4,852
-4,884
-4,224
-3,590
-3,179
Interest Expense
556.388
416.057
121.556
141.675
89.777
Total Other Income/Expenses Net
511.447
327.773
461.653
2,771
-2.01
Income Before Tax
-4,787
-4,850
-3,846
-960.178
-3,261
Income from Continuing Operations
-4,787
-4,850
-3,846
-960.178
-3,261
Net Income
-4,800
-4,605
-3,717
-960.178
-3,261
Net Income available to common shareholders
-4,800
-4,605
-3,717
-960.178
-3,261
Basic EPS
-
-0.04
-0.03
-0.01
-0.04
Diluted EPS
-
-0.04
-0.03
-0.01
-0.04
Basic Average Shares
-
112,600
107,549
101,532
80,114
Diluted Average Shares
-
112,600
107,549
101,532
80,114
EBITDA
-
-4,246
-3,646
-764.079
-3,099